Resistant gram-negative bacilli: A neglected healthcare crisis? (Q37009600)

17 August 2017

Resistant gram-negative bacilli: A neglected healthcare crisis? (English)

1 reference

17 August 2017

Gram-negative bacteria

0 references

author name string

Ebbing Lautenbach

series ordinal

1

1 reference

PubMed ID

18029939

17 August 2017

Ron E Polk

series ordinal

2

1 reference

17 August 2017

1 December 2007

1 reference

American Journal of Health-System Pharmacy

17 August 2017

1 reference

17 August 2017

64

1 reference

17 August 2017

23 Suppl 14

1 reference

17 August 2017

S3-21; quiz S22-4

1 reference

Multidrug-resistant gram-negative pathogens: multiple approaches and measures for prevention

17 August 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Trends in antimicrobial drug development: implications for the future

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Reemergence of gram-negative health care-associated bloodstream infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Pseudomonas aeruginosa contamination of mouth swabs during production causing a major outbreak

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

An outbreak of Pseudomonas aeruginosa infection caused by contaminated mouth swabs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Distribution of Acinetobacter species on skin of healthy humans

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Overview of nosocomial infections caused by gram-negative bacilli

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The epidemiology and control of Acinetobacter baumannii in health care facilities

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

A cluster of nosocomial Klebsiella pneumoniae bloodstream infections in a neonatal intensive care department: Identification of transmission and intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit linked to onychomycosis in a healthcare worker

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Epidemiology of drug resistance: implications for a post-antimicrobial era

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The impact of antimicrobial resistance on health and economic outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Are quinolone-resistant uropathogenic Escherichia coli less virulent?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Antimicrobial stewardship

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Antimicrobial stewardship programs in health care systems

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Antibiotic resistance--squeezing the balloon?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Systematic review of antimicrobial drug prescribing in hospitals.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Role of infectious diseases consultants in management of antimicrobial use in hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Pharmacokinetics and pharmacodynamics of antimicrobials

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070477

31 March 2020

Identifiers

DOI

10.2146/AJHP070477

1 reference

17 August 2017

1 reference

PubMed ID

18029939